MEDULLA OSSIUM GL D 30 ampoules

Pack size:10 x 1 ml Dosage form:Ampoules

Medulla ossium Gl D30, liquid dilution for injection. Active ingredient: Medulla ossium rubra bovis Gl. Indications: In accordance with anthroposophical knowledge of man and nature. These include: stimulation of bone marrow activity in blood formation disorders, adjunctive treatment of aplastic anemia and malignant bone marrow diseases.

For risks and side effects, read the package insert and ask your doctor or pharmacist.


INSTRUCTIONS FOR USE: INFORMATION FOR THE USER

Medulla ossium Gl D30, liquid dilution for injection
Active ingredient: Medulla ossium rubra bovis Gl

Composition:
1 ampoule contains: Medulla ossium rubra bovis Gl Dil. D30 1 ml (HAB, Vs. 41a).

Indications:
In accordance with anthroposophical knowledge of man and nature. These include: Stimulation of bone marrow activity in cases of blood formation disorders%%% Accompanying treatment of aplastic anemia and malignant bone marrow diseases.

Contraindications:
Do not use in patients following a bone marrow transplant.

Precautions for use and warnings:
There is no adequately documented experience with the use of this medicine in children. Therefore, it should only be used in children under 12 years of age after consultation with a doctor.

Dosage and method of administration:
Unless otherwise prescribed, inject 1 ml subcutaneously once a week to once daily.

Duration of use:
The duration of treatment of chronic diseases requires consultation with a doctor.

Side effects:
None known.

Contents:
10 x 1 ml.

Pharmaceutical entrepreneur and manufacturer:
WALA Heilmittel GmbH
Dorfstraße 1
73087 Bad Boll/Eckwälden.

This package leaflet was last revised in January 2025.

Source: Information from the Wala catalog,
as of: 05/2024

Active ingredient: Medulla ossium rubra bovis Gl. Indications: According to anthroposophical understanding of man and nature. These include: stimulation of bone marrow activity in cases of blood disorders, adjunctive treatment of aplastic anemia and malignant bone marrow diseases.